Aysun Dauti Isiklar, Sibel Ocak Serin


Introduction: An increase in diabetes mellitus (DM) causes different complaints and concerns. This retrospective cross-sectional study aimed to test fasting blood glucose (FBG) levels in patients presenting with erectile dysfunction (ED).

Materials and Methods: The patients included in the study were divided into two groups. Test group X consisted of 92 male patients who were referred to the urology outpatient clinic with the complaint of ED and did not have a previous DM history. Control group Y was formed with the same number of patients who applied to the internal medicine outpatient clinic for other complaints.

Results: The mean FBG levels were 133.7 ± 77.3 mg/dL in the group with ED and 102.7 ± 24.3 mg/dL in the control group. There was a significant correlation between the two groups in impaired fasting glucose (IFG) values (p<0.05).

Conclusion: Therefore, the measurement of fasting blood sugar is an essential diagnostic step in evaluating patients with ED.


fasting blood glucose, erectile dysfunction, diabetes mellitus

Full Text:



The National Institutes of Health (NIH). Consensus development conference on impotence. Dec.1992.

Schwarz ER, Kapur V, Bionat S, Rastogi S, Gupta R, Rosanio S. The prevalence and clinical relevance of sexual dysfunction in women and men with chronic heart failure. Int J Impot Res. 2008;20(1):85-91. doi: 10.1038/sj.ijir.3901613.

Latini DM, Penson DF, Lubeck DP, Wallace KL, Henning JM, Lue TF. Longitudinal differences in disease specific quality of life in men with erectile dysfunction: results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction study. J Urol. 2003;169(4):1437-42. doi: 10.1097/01.ju.0000049203.33463.9e

Lopushnyan NA, Chitaley K. Genetics of erectile dysfunction. J Urol. 2012;188(5):1676-83. doi: 10.1016/j.juro.2012.07.008.

Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. J Urol. 2000;163(2):460-3.

Miner M, Seftel AD, Nehra A, Ganz P, Kloner RA, Montorsi P, et al Prognostic utility of erectile dysfunction for cardiovascular disease in younger men and those with diabetes. Am Heart J. 2012;164(1):21-8. doi: 10.1016/j.ahj.2012.04.006.

Nehra A, Jackson G, Miner M, Billups KL, Burnett AL, Buvat J, et al. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc. 2012;87(8):766-78. doi: 10.1016/j.mayocp.2012.06.015.

World Health Organization & International Diabetes Federation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia : report of a WHO/IDF consultation. World Health Organization.2006.

Hanley AJ, Karter AJ, Williams K, Festa A, D'Agostino RB Jr, Wagenknecht LE, et al. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study. Circulation. 2005;112(24):3713-21. doi: 10.1161/CIRCULATIONAHA.105.559633.

Hoffman-Snyder C, Smith BE, Ross MA, Hernandez J, Bosch EP. Value of the oral glucose tolerance test in the evaluation of chronic idiopathic axonal polyneuropathy. Arch Neurol. 2006;63(8):1075-9. doi: 10.1001/archneur.63.8.noc50336.

Yesil Y, Altun BU. Electroneuromyiographic examination of peripheral nerves and brake in individuals with impaired fasting glucose, impaired glucose tolerance, well-controlled and poorly-controlled diabetes mellitus. Master thesis, Trakya University Faculty of Medicine.2006.

Singleton JR, Smith AG, Russell JW, Feldman EL. Microvascular complications of impaired glucose tolerance. Diabetes. 2003;52(12):2867-73. doi: 10.2337/diabetes.52.12.2867.

El-Sakka AI, Tayeb KA. Erectile dysfunction risk factors in noninsulin dependent diabetic Saudi patients. J Urol. 2003;169(3):1043-7. doi: 10.1097/01.ju.0000050080.21839.f9.

Thethi TK, Asafu-Adjaye NO, Fonseca VA. Erectile dysfunction. Clin. Diabetes. 2005; 23: 105-13.

Singleton JR, Smith AG, Russell JW, Feldman EL. Microvascular complications of impaired glucose tolerance. Diabetes. 2003;52(12):2867-73. doi: 10.2337/diabetes.52.12.2867.

Moulik PK, Hardy KJ. Hypertension, anti-hypertensive drug therapy and erectile dysfunction in diabetes. Diabet Med. 2003;20(4):290-3. doi: 10.1046/j.1464-5491.2003.00911.x.

Grover SA, Lowensteyn I, Kaouache M, Marchand S, Coupal L, DeCarolis E, et al. The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease. Arch Intern Med. 2006;166(2):213-9. doi: 10.1001/archinte.166.2.213.

Hecht MJ, Neundörfer B, Kiesewetter F, Hilz MJ. Neuropathy is a major contributing factor to diabetic erectile dysfunction. Neurol Res. 2001;23(6):651-4. doi: 10.1179/016164101101198965.

Jensen J, Lendorf A, Stimpel H, Frost J, Ibsen H, Rosenkilde P. The prevalence and etiology of impotence in 101 male hypertensive outpatients. Am J Hypertens. 1999;12(3):271-5. doi: 10.1016/s0895-7061(98)00225-8.

Olafimihan KO, Ayinmode BA, Odeigah LO, Akande A. Erectile dysfunction in the aging man. International Journal of Medicine and Medical Sciences. 2010; 2(11):342-6.

Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study. Lancet. 1980;1(8183):1373-6. doi: 10.1016/s0140-6736(80)92651-3.

Alberti KG. The clinical implications of impaired glucose tolerance. Diabet Med. 1996;13(11):927-37. doi: 10.1002/(SICI)1096-9136(199611)13:11<927::AID-DIA279>3.0.CO;2-E.



  • There are currently no refbacks.

Copyright (c) 2021 Aysun Dauti Isiklar, Sibel Ocak Serin

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.